Template:Sedative agents: Difference between revisions
(Convert to MedicationDose template — single source of truth with SMW; verify all dosing; fix etomidate procedural sedation content) |
|||
| Line 4: | Line 4: | ||
*[[Propofol]] is often used for orthopedic procedures due to muscle relaxation, but can cause respiratory depression and hypotension | *[[Propofol]] is often used for orthopedic procedures due to muscle relaxation, but can cause respiratory depression and hypotension | ||
*[[Etomidate]] used less frequently than other agents; causes myoclonus that is undesirable for orthopedic reduction | *[[Etomidate]] used less frequently than other agents; causes myoclonus that is undesirable for orthopedic reduction | ||
===[[Ketamine]]=== | ===[[Ketamine]]=== | ||
*Noncompetitive NMDA receptor antagonist that produced dissociative state | *Noncompetitive NMDA receptor antagonist that produced dissociative state | ||
| Line 9: | Line 10: | ||
*Safe to use in children undergoing procedural sedation and analgesia (Level A recommendation)<ref name="ACEP">ACEP Clinical Policy: Procedural Sedation and Analgesia in the Emergency Department [http://www.acep.org/workarea/DownloadAsset.aspx?id=93816 full text]</ref> | *Safe to use in children undergoing procedural sedation and analgesia (Level A recommendation)<ref name="ACEP">ACEP Clinical Policy: Procedural Sedation and Analgesia in the Emergency Department [http://www.acep.org/workarea/DownloadAsset.aspx?id=93816 full text]</ref> | ||
*Maintains upper airway tone, protective reflexes, and spontaneous breathing | *Maintains upper airway tone, protective reflexes, and spontaneous breathing | ||
*Little evidence to advocate for prevention of emergence phenomenon, may pretreat with midazolam 0.05 mg/kg (2-4 mg for most adults)<ref>Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without | *Little evidence to advocate for prevention of emergence phenomenon, may pretreat with midazolam 0.05 mg/kg (2-4 mg for most adults)<ref>Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med. 2011 Feb;57(2):109-114.e2</ref> | ||
**Versed can be used subsequently if emergence reaction occurs | **Versed can be used subsequently if emergence reaction occurs | ||
*{{MedicationDose|drug=Ketamine|dose=1-2 mg/kg|route=IV|context=Procedural sedation|indication=Procedural sedation|population=Adult|duration=10-20 min|notes=Followed by 0.5-1 mg/kg IV PRN}} | |||
*1-2 mg/kg IV | *{{MedicationDose|drug=Ketamine|dose=4-5 mg/kg|route=IM|context=Procedural sedation (IM)|indication=Procedural sedation|population=Adult|duration=10-20 min|notes=Repeat 2-4 mg/kg IM after 10 min if unsuccessful}} | ||
*4-5 mg/kg IM | *{{MedicationDose|drug=Ketamine|dose=1.5-2 mg/kg|route=IV|context=Procedural sedation|indication=Procedural sedation|population=Pediatric|notes=Safe for children (Level A)}} | ||
* | *{{MedicationDose|drug=Ketamine|dose=4-5 mg/kg|route=IM|context=Procedural sedation (IM)|indication=Procedural sedation|population=Pediatric}} | ||
*{{MedicationDose|drug=Ketamine|dose=3-6 mg/kg|route=IN|context=Procedural sedation (IN)|indication=Procedural sedation|population=Pediatric}}<ref>Hall, D, et al. Intranasal ketamine for procedural sedation. Emerg Med J. 2014; 31:789-90.</ref> | |||
===[[Propofol]]=== | ===[[Propofol]]=== | ||
*Potentiates GABA receptors, sedative hypnotic agent without analgesic properties | *Potentiates GABA receptors, sedative hypnotic agent without analgesic properties | ||
*Rapid onset <1 min, short duration <10 min, predictable dose dependent potency | *Rapid onset <1 min, short duration <10 min, predictable dose dependent potency | ||
*0.5- | *{{MedicationDose|drug=Propofol|dose=0.5-1 mg/kg IV over 3-5 min|route=IV|context=Procedural sedation|indication=Procedural sedation|population=Adult|onset=<1 min|duration=<10 min|notes=Repeat 0.5 mg/kg q3-5 min PRN}} | ||
*Can cause dose-related respiratory depression, hypotension, and decreased cardiac output, however, rarely leads to unplanned intubation, prolonged observation, or complications requiring admission <ref> Blackburn 2000, Burnton JH, Miner JR, et al. Propofol for emergency department procedural sedation and analgesia: a tale of three centers. | *Can cause dose-related respiratory depression, hypotension, and decreased cardiac output, however, rarely leads to unplanned intubation, prolonged observation, or complications requiring admission <ref> Blackburn 2000, Burnton JH, Miner JR, et al. Propofol for emergency department procedural sedation and analgesia: a tale of three centers. Acad Emerg Med. 2006;13(1):24-30 </ref> | ||
===[[Fentanyl]]/[[Midazolam]]=== | ===[[Fentanyl]]/[[Midazolam]]=== | ||
* | *{{MedicationDose|drug=Fentanyl|dose=0.5-1 mcg/kg|route=IV|context=Procedural sedation (with midazolam)|indication=Procedural sedation|population=Adult|notes=Dose fentanyl first}} | ||
* | *{{MedicationDose|drug=Midazolam|dose=1-2 mg|route=IV|context=Procedural sedation (with fentanyl)|indication=Procedural sedation|population=Adult|duration=30 min|notes=Follow fentanyl; designed for moderate sedation}} | ||
*Combination of other [[opioids]] with [[benzodiazepines]] such as [[lorazepam]] is possible | |||
===[[Fentanyl]]/[[Etomidate]]=== | ===[[Fentanyl]]/[[Etomidate]]=== | ||
*Similar to | *Similar to fentanyl/midazolam, but better because shorter duration of action | ||
*An alternative to propofol for brief sedation | *An alternative to propofol for brief sedation (e.g. shoulder/hip reduction, cardioversion) | ||
*Can cause myoclonus<ref> Van Keulen SG, Burton JH. Myoclonus associated with etomidate for ED procedural sedation and analgesia. Am J Emerg Med. 2003;21:556-558.</ref> | |||
*Can cause myoclonus<ref> Van Keulen SG, Burton JH. Myoclonus associated with etomidate for ED procedural sedation and analgesia. Am J Emerg Med. 2003;21:556-558.</ref> | *{{MedicationDose|drug=Fentanyl|dose=0.5-1 mcg/kg|route=IV|context=Procedural sedation (with etomidate)|indication=Procedural sedation|population=Adult|notes=Dose fentanyl first}} | ||
* | *{{MedicationDose|drug=Etomidate|dose=0.15 mg/kg|route=IV|context=Procedural sedation|indication=Procedural sedation|population=Adult|duration=6 min|notes=Average 8-10 mg}} | ||
*Etomidate 0. | |||
===Brevital (Methohexital)/[[Fentanyl]]=== | ===Brevital (Methohexital)/[[Fentanyl]]=== | ||
*Suppresses the reticular activating center in the brainstem and cerebral cortex, thereby causing sedation | *Suppresses the reticular activating center in the brainstem and cerebral cortex, thereby causing sedation | ||
*Sedation and amnesia, no analgesia | *Sedation and amnesia, no analgesia | ||
* | *{{MedicationDose|drug=Fentanyl|dose=0.5-1 mcg/kg|route=IV|context=Procedural sedation (with brevital)|indication=Procedural sedation|population=Adult|notes=Dose fentanyl first}} | ||
* | *{{MedicationDose|drug=Methohexital|dose=0.75-1 mg/kg|route=IV|context=Procedural sedation|indication=Procedural sedation|population=Adult|onset=immediate|duration=<10 min|display=Brevital|notes=Repeat 0.5 mg/kg IV q2 min PRN}} | ||
===[[Propofol]]/[[Ketamine]] ([[Ketofol]])=== | ===[[Propofol]]/[[Ketamine]] ([[Ketofol]])=== | ||
*1:1 mixture of ketamine and propofol<ref>Andolfatto G, Abu-Laban RB, Zed PJ, et al. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: a randomized double-blind trial. Ann Emerg Med. 2012; 59(6): 504-12.e1-2. PMID: 22401952</ref> | *1:1 mixture of ketamine and propofol<ref>Andolfatto G, Abu-Laban RB, Zed PJ, et al. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: a randomized double-blind trial. Ann Emerg Med. 2012; 59(6): 504-12.e1-2. PMID: 22401952</ref> | ||
*Safe in children and adults undergoing procedural sedation and anesthesia (Level B | *Safe in children and adults undergoing procedural sedation and anesthesia (Level B Recommendation)<ref name="ACEP">ACEP Clinical Policy: Procedural Sedation and Analgesia in the Emergency Department [http://www.acep.org/workarea/DownloadAsset.aspx?id=93816 full text]</ref> | ||
*Theorized that side-effect profiles counter one another | *Theorized that side-effect profiles counter one another | ||
**Propofol-associated hypotension and respiratory depression can theoretically be reduced with increases in circulatory norepinephrine induced by ketamine | **Propofol-associated hypotension and respiratory depression can theoretically be reduced with increases in circulatory norepinephrine induced by ketamine | ||
**Ketamine associated nausea and emergence reactions are theoretically reduced by the antiemetic and anxiolytic properties of propofol | **Ketamine associated nausea and emergence reactions are theoretically reduced by the antiemetic and anxiolytic properties of propofol | ||
*A study of pediatric patients found the total patient sedation times to be shorter (3 minutes) with the combined ketamine and propofol regimen compared with ketamine alone<ref>Shah A, Mosdossy G, McLeod S, et al. A blinded, randomized controlled trial to evaluate ketamine/propofol versus ketamine alone for procedural sedation in children. Ann Emerg Med. 2011;57:425-433.</ref> | *A study of pediatric patients found the total patient sedation times to be shorter (3 minutes) with the combined ketamine and propofol regimen compared with ketamine alone<ref>Shah A, Mosdossy G, McLeod S, et al. A blinded, randomized controlled trial to evaluate ketamine/propofol versus ketamine alone for procedural sedation in children. Ann Emerg Med. 2011;57:425-433.</ref> | ||
* | *{{MedicationDose|drug=Ketofol|dose=0.5 mg/kg propofol + 0.5 mg/kg ketamine|route=IV|context=Procedural sedation|indication=Procedural sedation|population=Adult|notes=May be mixed in same syringe or given separately}} | ||
===[[Dexmedetomidine]]=== | ===[[Dexmedetomidine]]=== | ||
*1 mcg/kg loading | *{{MedicationDose|drug=Dexmedetomidine|dose=1 mcg/kg loading then 0.2-1 mcg/kg/hr|route=IV|context=Procedural sedation|indication=Procedural sedation|population=Adult|notes=Avoid in heart blocks; may supplement with midazolam 1-2 mg}} | ||
*Side effects include bradycardia and hypotension | |||
===[[Etomidate]]=== | ===[[Etomidate]]=== | ||
{{ | *{{MedicationDose|drug=Etomidate|dose=0.1-0.2 mg/kg|route=IV|context=Procedural sedation (solo)|indication=Procedural sedation|population=Adult|notes=One-time dosing; max 10 mg}} | ||
Latest revision as of 15:48, 20 March 2026
Sedative agents
- The ideal agent is short-acting with minimal respiratory or hemodynamic depression
- Ketamine offers the greatest safety profile overall but caution in the elderly or patients with known cardiovascular disease due to sympathetic surge
- Propofol is often used for orthopedic procedures due to muscle relaxation, but can cause respiratory depression and hypotension
- Etomidate used less frequently than other agents; causes myoclonus that is undesirable for orthopedic reduction
Ketamine
- Noncompetitive NMDA receptor antagonist that produced dissociative state
- Sedation, analgesia, and amnesia
- Safe to use in children undergoing procedural sedation and analgesia (Level A recommendation)[1]
- Maintains upper airway tone, protective reflexes, and spontaneous breathing
- Little evidence to advocate for prevention of emergence phenomenon, may pretreat with midazolam 0.05 mg/kg (2-4 mg for most adults)[2]
- Versed can be used subsequently if emergence reaction occurs
- Ketamine 1-2 mg/kg IV (duration 10-20 min) — Followed by 0.5-1 mg/kg IV PRN
- Ketamine 4-5 mg/kg IM (duration 10-20 min) — Repeat 2-4 mg/kg IM after 10 min if unsuccessful
- Ketamine 1.5-2 mg/kg IV — Safe for children (Level A)
- Ketamine 4-5 mg/kg IM
- Ketamine 3-6 mg/kg IN[3]
Propofol
- Potentiates GABA receptors, sedative hypnotic agent without analgesic properties
- Rapid onset <1 min, short duration <10 min, predictable dose dependent potency
- Propofol 0.5-1 mg/kg IV over 3-5 min IV (onset <1 min, duration <10 min) — Repeat 0.5 mg/kg q3-5 min PRN
- Can cause dose-related respiratory depression, hypotension, and decreased cardiac output, however, rarely leads to unplanned intubation, prolonged observation, or complications requiring admission [4]
Fentanyl/Midazolam
- Fentanyl 0.5-1 mcg/kg IV — Dose fentanyl first
- Midazolam 1-2 mg IV (duration 30 min) — Follow fentanyl; designed for moderate sedation
- Combination of other opioids with benzodiazepines such as lorazepam is possible
Fentanyl/Etomidate
- Similar to fentanyl/midazolam, but better because shorter duration of action
- An alternative to propofol for brief sedation (e.g. shoulder/hip reduction, cardioversion)
- Can cause myoclonus[5]
- Fentanyl 0.5-1 mcg/kg IV — Dose fentanyl first
- Etomidate 0.15 mg/kg IV (duration 6 min) — Average 8-10 mg
Brevital (Methohexital)/Fentanyl
- Suppresses the reticular activating center in the brainstem and cerebral cortex, thereby causing sedation
- Sedation and amnesia, no analgesia
- Fentanyl 0.5-1 mcg/kg IV — Dose fentanyl first
- Brevital 0.75-1 mg/kg IV (onset immediate, duration <10 min) — Repeat 0.5 mg/kg IV q2 min PRN
Propofol/Ketamine (Ketofol)
- 1:1 mixture of ketamine and propofol[6]
- Safe in children and adults undergoing procedural sedation and anesthesia (Level B Recommendation)[1]
- Theorized that side-effect profiles counter one another
- Propofol-associated hypotension and respiratory depression can theoretically be reduced with increases in circulatory norepinephrine induced by ketamine
- Ketamine associated nausea and emergence reactions are theoretically reduced by the antiemetic and anxiolytic properties of propofol
- A study of pediatric patients found the total patient sedation times to be shorter (3 minutes) with the combined ketamine and propofol regimen compared with ketamine alone[7]
- Ketofol 0.5 mg/kg propofol + 0.5 mg/kg ketamine IV — May be mixed in same syringe or given separately
Dexmedetomidine
- Dexmedetomidine 1 mcg/kg loading then 0.2-1 mcg/kg/hr IV — Avoid in heart blocks; may supplement with midazolam 1-2 mg
- Side effects include bradycardia and hypotension
Etomidate
- Etomidate 0.1-0.2 mg/kg IV — One-time dosing; max 10 mg
- ↑ 1.0 1.1 ACEP Clinical Policy: Procedural Sedation and Analgesia in the Emergency Department full text
- ↑ Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med. 2011 Feb;57(2):109-114.e2
- ↑ Hall, D, et al. Intranasal ketamine for procedural sedation. Emerg Med J. 2014; 31:789-90.
- ↑ Blackburn 2000, Burnton JH, Miner JR, et al. Propofol for emergency department procedural sedation and analgesia: a tale of three centers. Acad Emerg Med. 2006;13(1):24-30
- ↑ Van Keulen SG, Burton JH. Myoclonus associated with etomidate for ED procedural sedation and analgesia. Am J Emerg Med. 2003;21:556-558.
- ↑ Andolfatto G, Abu-Laban RB, Zed PJ, et al. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: a randomized double-blind trial. Ann Emerg Med. 2012; 59(6): 504-12.e1-2. PMID: 22401952
- ↑ Shah A, Mosdossy G, McLeod S, et al. A blinded, randomized controlled trial to evaluate ketamine/propofol versus ketamine alone for procedural sedation in children. Ann Emerg Med. 2011;57:425-433.
